Metronomic oral gemcitabine for cancer therapy
Use of gemcitabine, including in self-emulsifying orally administered dosage forms for treatment, such as inducing regression or inhibiting growth, of tumors in a patient such as a human. Gemcitabine is orally administered in a metronomic manner.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
20.12.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Use of gemcitabine, including in self-emulsifying orally administered dosage forms for treatment, such as inducing regression or inhibiting growth, of tumors in a patient such as a human. Gemcitabine is orally administered in a metronomic manner. |
---|---|
Bibliography: | Application Number: AU20170273495 |